ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2415

Giant Cell Arteritis Is Associated with Worse Hospital Outcomes in Aortic Aneurysm/Dissection Hospitalizations: A Nationwide United States Population-Based Study

Artem Minalyan1, Christopher Hino1, Emily He1, Osahon Idolor2, Chinenye Osuorji3, Nneka Chukwu4, Ehizogie Edigin1 and Vaneet Sandhu5, 1Loma Linda University Health, Loma Linda, CA, 2Piedmont Athens Regional Hospital, Atlanta, GA, 3Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, 4Nuvance Health Internal Medicine Residency, Poughkeepsie, NY, 5Loma Linda University, Loma Linda, CA

Meeting: ACR Convergence 2023

Keywords: giant cell arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2387–2424) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant Cell Arteritis (GCA) is a known risk factor for Aortic Aneurysm/Dissection (AAD). However, it is unclear if patients with GCA have worse hospital outcomes when hospitalized for AAD compared to patients without GCA hospitalized for AAD. We queried the largest inpatient hospitalization database in the United States (U.S.) to answer this question.

Methods: Data were abstracted from the National Inpatient Sample (NIS) from 2016 to 2020 Database. NIS is a nationally representative approximate 20-percent stratified sample of all discharges from U.S. community hospitals, excluding rehabilitation and long-term acute care hospitals. The numbers in the databases are weighted to optimize national estimates. The NIS was searched for hospitalizations for patients aged ≥ 50 years with a principal diagnosis of AAD (“I71”) with and without a coexisting secondary diagnosis of GCA (“M315” and “M316”) using ICD-10 codes. The principal diagnosis is the main reason for hospitalization. Any diagnosis other than the principal is a secondary diagnosis. Each hospitalization in the NIS has only 1 principal diagnosis and can have up to 40 secondary diagnoses. The chi-square test was used to compare baseline characteristics between the GCA and non-GCA groups. The primary outcome was inpatient mortality. Hospital length of stay (LOS) and total hospital charges were secondary outcomes. Multivariable logistic and linear regression analyses were used to adjust for confounders for the primary and secondary outcomes, respectively. We adjusted for age, gender, race, insurance type, income, Charlson co-morbidity index, and hospital characteristics. STATA version 16 was used for analysis. Since NIS contains publicly available depersonalized data, Institutional Review Board (IRB) review was waived.

Results: There were about 175 million hospitalizations in the combined 2016-2020 database. We obtained 314,215 hospitalizations for patients aged ≥ 50 years with a principal diagnosis of AAD. 685 (0.2%) of these had a secondary diagnosis of GCA, while 313,530 (99.8%) did not have co-existing GCA. The GCA group was older (mean age of 74.6 vs 71.8 years, p < 0.0001) and had more females (76.6% vs 29.5%, p < 0.001) compared to the non-GCA group. The GCA group had similar inpatient mortality compared to the non-GCA group (6.4% vs 6.6%, p=0.627). The GCA group had longer LOS (9.4 vs 5.5 days, p < 0.0001) and higher total hospital charges ($224,540 vs 180,356, p=0.002) compared to the non-GCA group. See table 1.

Conclusion: GCA patients admitted for AAD have worse hospital outcomes (longer LOS and higher total hospital charges) compared to non-GCA patients admitted for AAD. Adequate treatment of GCA to prevent complications such as AAD is needed. In addition, screening, early detection, and prompt management of AAD via a multidisciplinary approach are essential in optimizing the outcomes of GCA patients.

Supporting image 1

Table 1: Hospital outcomes of Aortic Aneurysm/Dissection hospitalizations with and without Giant
Cell Arteritis


Disclosures: A. Minalyan: None; C. Hino: None; E. He: None; O. Idolor: None; C. Osuorji: None; N. Chukwu: None; E. Edigin: None; V. Sandhu: Exagen, 2, 5.

To cite this abstract in AMA style:

Minalyan A, Hino C, He E, Idolor O, Osuorji C, Chukwu N, Edigin E, Sandhu V. Giant Cell Arteritis Is Associated with Worse Hospital Outcomes in Aortic Aneurysm/Dissection Hospitalizations: A Nationwide United States Population-Based Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/giant-cell-arteritis-is-associated-with-worse-hospital-outcomes-in-aortic-aneurysm-dissection-hospitalizations-a-nationwide-united-states-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/giant-cell-arteritis-is-associated-with-worse-hospital-outcomes-in-aortic-aneurysm-dissection-hospitalizations-a-nationwide-united-states-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology